Phase II trial of concurrent 5-fluorouracil, hydroxyurea, cetuximab, and intensity moduled radiation therapy (IMRT) for locally advanced head and neck cancer

被引：0
|
作者：
Kao, J. [1 ]
Policarpio, L. [1 ]
Teng, M. [1 ]
Burri, R. [1 ]
Genden, E. [1 ]
Packer, S. [1 ]
机构：
[1] Mt Sinai Sch Med, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6014
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase 2 Trial of Concurrent 5-Fluorouracil, Hydroxyurea, Cetuximab, and Hyperfractionated Intensity-Modulated Radiation Therapy for Locally Advanced Head and Neck Cancer
    Kao, Johnny
    Genden, Eric M.
    Gupta, Vishal
    Policarpio, Edelweiss L.
    Burri, Ryan J.
    Rivera, Michael
    Gurudutt, Vivek
    Som, Peter M.
    Teng, Marita
    Packer, Stuart H.
    CANCER, 2011, 117 (02) : 318 - 326
  • [2] Prognostic significance of p16 in locoregionally advanced head and neck cancer treated with concurrent 5-fluorouracil, hydroxyurea, cetuximab and intensity-modulated radiation therapy
    Tong, Charles C. L.
    Lau, K. H. Vincent
    Rivera, Michael
    Cannan, David
    Aguirre-Ghiso, Julio
    Sikora, Andrew G.
    Gupta, Vishal
    Forsythe, Kevin
    Ko, Eric C.
    Misiukiewicz, Krzysztof
    Gurudutt, Vivek
    Teng, Marita S.
    Packer, Stuart H.
    Genden, Eric M.
    Kao, Johnny
    ONCOLOGY REPORTS, 2012, 27 (05) : 1580 - 1586
  • [3] The Prognostic Significance of p16 in Patients with Locoregionally Advanced Head and Neck Cancer Treated with Concurrent 5-Fluorouracil, Hydroxyurea, Cetuximab, and IMRT
    Lau, K.
    Tong, C. C. L.
    Rivera, M.
    Packer, S. H.
    Cannan, D.
    Teng, M. S.
    Sikora, A. G.
    Gupta, V.
    Genden, E. M.
    Kao, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S485 - S486
  • [4] Efficacy of concurrent cetuximab vs. 5-fluorouracil/carboplatin or high-dose cisplatin with intensity-modulated radiation therapy (IMRT) for locally-advanced head and neck cancer (LAHNSCC)
    Shapiro, Lauren Q.
    Sherman, Eric J.
    Riaz, Nadeem
    Setton, Jeremy
    Koutcher, Lawrence
    Zhang, Zhigang
    Shi, Weiji
    Fury, Matthew G.
    Wolden, Suzanne L.
    Pfister, David G.
    Morris, Luc
    Lee, Nancy
    ORAL ONCOLOGY, 2014, 50 (10) : 947 - 955
  • [5] Efficacy of concurrent cetuximab (C225) versus 5-fluorouracil/carboplatin (5FU/CBDCA) or cisplatin (CDDP) with intensity-modulated radiation therapy (IMRT) for locally advanced head and neck cancer (LAHNSCC).
    Shapiro, Lauren Quinn
    Sherman, Eric Jeffrey
    Koutcher, Lawrence
    Setton, Jeremy
    Zhang, Zhigang
    Shi, Weiji
    Rao, Shyam S.
    Fury, Matthew G.
    Wolden, Suzanne L.
    Kraus, Dennis
    Pfister, David G.
    Lee, Nancy Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Paclitaxel, 5-fluorouracil and hydroxyurea concurrent with radiation in locally advanced nasopharyngeal carcinoma
    Wong, A. S. C.
    Soo, R. A.
    Lu, J. J.
    Loh, K. S.
    Tan, K. S.
    Hsieh, W. S.
    Shakespeare, T. P.
    Chua, E. T.
    Lim, H. L.
    Goh, B. C.
    ANNALS OF ONCOLOGY, 2006, 17 (07) : 1152 - 1157
  • [7] Cetuximab versus cisplatin concurrent with IMRT in locally advanced head and neck cancer (LAHNC)
    Galper, S. L.
    Deshpande, H.
    Rose, M. G.
    Decker, R. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [8] Radiation therapy with 5-fluorouracil in head and neck cancer
    Fu, KK
    SEMINARS IN RADIATION ONCOLOGY, 1997, 7 (04) : 274 - 282
  • [9] A retrospective study of induction chemotherapy with docetaxel, cisplatinum, and 5-fluorouracil followed by concurrent radiotherapy with cetuximab in locally advanced head and neck cancer
    Kim, Brian
    Dillman, Robert O.
    Chen, Peter
    Hafer, Russell
    Cox, Craig
    Barth, Neil
    Carroll, Matthew
    VanderMolen, Louis
    Nguyen, Minh
    Huang, JinChu
    Minion, Annamarie
    Plunkett, Marianne
    Mackintosh, Ralph
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2012, 33 (01) : 93 - 97
  • [10] Concurrent Intensity Modulated Radiation Therapy (IMRT) With Cisplatin (CDDP) versus 5-Fluorouracil/Carboplatin (5FU/P) For Head and Neck Cancer (HNC)
    Shapiro, L. Q.
    Setton, J.
    Zhang, Z.
    Shi, W.
    Rao, S. D.
    Wolden, S. A.
    Sherman, E. J.
    Kraus, D. H.
    Pfister, D. G.
    Lee, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S493 - S493
12345